IgA: structure, function, and developability

P de Sousa-Pereira, JM Woof - Antibodies, 2019 - mdpi.com
Immunoglobulin A (IgA) plays a key role in defending mucosal surfaces against attack by
infectious microorganisms. Such sites present a major site of susceptibility due to their vast …

Technology trends in antibody purification

P Gagnon - Journal of chromatography A, 2012 - Elsevier
This article reviews technology trends in antibody purification. Section 1 discusses non-
chromatography methods, including precipitation, liquid–liquid extraction, and high …

[HTML][HTML] The human immunoglobulin A Fc receptor FcαRI: a multifaceted regulator of mucosal immunity

JE Bakema, M Van Egmond - Mucosal immunology, 2011 - Elsevier
Immunoglobulin A (IgA) is commonly recognized as the most prevalent antibody (Ab) at
mucosal sites with an important role in defense by shielding mucosal surfaces from invasion …

The era of the immunoglobulin A Fc receptor Fcα RI; its function and potential as target in disease

E Aleyd, MH Heineke, M van Egmond - Immunological reviews, 2015 - Wiley Online Library
Immunoglobulin A (IgA) is the most prevalent antibody at mucosal sites, and has an
important role in defense by preventing invasion of pathogens. Traditionally, IgA has been …

Biotechnological applications of recombinant single-domain antibody fragments

A de Marco - Microbial cell factories, 2011 - Springer
Background Single-domain antibody fragments possess structural features, such as a small
dimension, an elevated stability, and the singularity of recognizing epitopes non-accessible …

IgA, IgA receptors, and their anti-inflammatory properties

SB Mkaddem, I Christou, E Rossato, L Berthelot… - Fc Receptors, 2014 - Springer
Immunoglobulin A (IgA) is the most abundantly produced antibody isotype in mammals. The
primary function of IgA is to maintain homeostasis at mucosal surfaces and play a role in …

Fc engineering strategies to advance IgA antibodies as therapeutic agents

G van Tetering, M Evers, C Chan, M Stip, J Leusen - Antibodies, 2020 - mdpi.com
In the past three decades, a great interest has arisen in the use of immunoglobulins as
therapeutic agents. In particular, since the approval of the first monoclonal antibody …

Neutrophils as effector cells for antibody-based immunotherapy of cancer

M van Egmond, JE Bakema - Seminars in cancer biology, 2013 - Elsevier
The use of monoclonal antibodies (mAbs) has become a mainstream strategy for the
treatment of cancer. After binding to the target antigen, they mediate a plethora of effector …

IgA EGFR antibodies mediate tumour killing in vivo

P Boross, S Lohse, M Nederend… - EMBO molecular …, 2013 - embopress.org
Currently all approved anti‐cancer therapeutic monoclonal antibodies (mAbs) are of the IgG
isotype, which rely on Fcgamma receptors (FcγRs) to recruit cellular effector functions. In …

Myeloid cells as effector cells for monoclonal antibody therapy of cancer

R Braster, T O'toole, M Van Egmond - Methods, 2014 - Elsevier
Monoclonal antibodies (mAbs) have become an important addition to chemo-and/or
radiotherapy for the treatment of cancer. They have multiple effector functions that can lead …